Studies on obese mice demonstrated significant fat reduction, even in those lacking beta-3 receptors, suggesting AOD-9604 promotes fat loss through additional pathways, enhancing energy use and offering a multifaceted approach to managing adipose tissues effectively (1)
Lose 14-15% of your body weight* *In clinical trials of Wegovy (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise
B12 injections deliver hydroxocobalamin (the preferred formulation in the UK) or cyanocobalamin directly into muscle tissue, bypassing the gastrointestinal tract to ensure rapid absorption into the bloodstream
Cyanocobalamin is more common because it works well and stays stable
They can be a reasonable supportive adjunct within a program, and they can correct genuine nutrient deficiencies